NCT05092555

Brief Summary

This study aims at determining clinical presentations and outcomes of patients with covid-19 pneumonia and also follow up of patients for up to 6 months to detect possibility of post covid fibrosis

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 25, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

November 2, 2021

Status Verified

October 1, 2021

Enrollment Period

7 months

First QC Date

October 22, 2021

Last Update Submit

October 26, 2021

Conditions

COVID-19 Pneumonia

Outcome Measures

Primary Outcomes (1)

  • Post covid fibrosis

    Possibility of occurrence of post covid fibrosis by follow up of patients for up to 6 month

    Six month

Interventions

Nasopharyngeal swap for Reverse transcription polymerase chain reactionDIAGNOSTIC_TEST

Nasopharyngeal swap and Blood sample is taken for doing previous tests and CT chest is done for all patients

Also known as: CT chest d-dimer C-reactive protein serum ferritin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with covid-19 pneumonia

You may qualify if:

  • Age ≥18 years old
  • Patients with covid-19 pneumonia confirmed by:
  • Reverse transcription polymerase chain reaction Or pattern of covid-19 in computed tomography (CT) scan ( ground-glass opacity indicative of pneumonia on CT, opinion on consolidation, etc) with laboratory investigations

You may not qualify if:

  • Patients not confirmed to be covid-19 with PCR or radiologically.
  • Patients who are diagnosed as bacterial pneumonia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Hamdy A Mohammadeen, Ass.prof

    Sohag University

    STUDY DIRECTOR

  • Mona T Hussen, Ass.prof

    Sohag University

    STUDY CHAIR

Central Study Contacts

Ghada M Bahy

CONTACT

+201063551135ghadabahy567@gmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chest resident

Study Record Dates

First Submitted

October 22, 2021

First Posted

October 25, 2021

Study Start

November 1, 2021

Primary Completion

June 1, 2022

Study Completion

July 1, 2022

Last Updated

November 2, 2021

Record last verified: 2021-10